Drugs / BioChaperone Human Insulin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02739906 | Apr → Aug 2016 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
| Phase 1/2 | NCT02213146 | Aug → Dec 2014 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BioChaperone Human Insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02739906 ↗ |
| Known as | HinsBet | “BioChaperone Human Insulin (HinsBet®) individualised single subcutaneous injection followed by test meal intake” NCT02739906 ↗ |
| Route | Subcutaneous | “Single dose of 0.2 U/kg body weight injected subcutaneously” NCT02213146 ↗ |